Effects of Morbid Obesity and Metabolic Syndrome on the Composition of Circulating Immune Subsets.
Adaptive Immunity
Adult
Aging
B-Lymphocytes
/ immunology
Body Mass Index
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
/ immunology
Cohort Studies
Female
Flow Cytometry
Humans
Killer Cells, Natural
/ immunology
Male
Metabolic Syndrome
/ immunology
Middle Aged
Monocytes
/ immunology
Obesity, Morbid
/ immunology
B cells
NK cells
T cells
metabolic syndrome
metaflammation
monocytes
morbid obesity
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
03
2021
accepted:
30
06
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
27
10
2021
Statut:
epublish
Résumé
Morbid obesity is characterized by chronic, low-grade inflammation, which is associated with 'inflamm-aging'. The presence of metabolic syndrome (MetS) might accelerate this phenomenon of metaflammation. In this study, we assessed the effects of morbid obesity and MetS on the composition of a broad spectrum of immune cells present within the circulation. A total of 117 morbidly obese patients (MOP) without MetS (MetS-), 127 MOP with MetS (MetS+) and 55 lean controls (LC) were included in this study. Absolute numbers of T cell, B cell, NK cell and monocyte subsets were assessed within peripheral blood using flow cytometry. Both absolute cell numbers and proportion of cells were evaluated correcting for covariates age, body mass index and cytomegalovirus serostatus. Although the absolute number of circulating CD4+ T cells was increased in the MetS+ group, the CD4+ T cell composition was not influenced by MetS. The CD8+ T cell and B cell compartment contained more differentiated cells in the MOP, but was not affected by MetS. Even though the absolute numbers of NK cells and monocytes were increased in the MOP as compared to LC, there was no difference in proportions of NK and monocyte subsets between the three study groups. In conclusion, although absolute numbers of CD4+ and CD8+ T cells, B cells, NK cells and monocytes are increased in MOP, obesity-induced effects of the composition of the immune system are confined to a more differentiated phenotype of CD8+ T cells and B cells. These results were not affected by MetS.
Identifiants
pubmed: 34354700
doi: 10.3389/fimmu.2021.675018
pmc: PMC8330422
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
675018Informations de copyright
Copyright © 2021 Wijngaarden, van der Harst, Klaassen, Dunkelgrun, Kuijper, Klepper, Ambagtsheer, IJzermans, de Bruin and Litjens.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Immunol. 2011 Dec 15;187(12):6208-16
pubmed: 22075699
J Clin Immunol. 2003 Jul;23(4):247-57
pubmed: 12959217
Am J Clin Nutr. 2011 Aug;94(2):450-8
pubmed: 21677057
J Clin Med. 2020 Apr 01;9(4):
pubmed: 32244612
Int J Stem Cells. 2008 Nov;1(1):55-63
pubmed: 24855509
J Clin Endocrinol Metab. 2004 Jun;89(6):2583-9
pubmed: 15181027
Stat Med. 2019 May 30;38(12):2248-2268
pubmed: 30761571
Clin Immunol. 2017 Apr;177:12-17
pubmed: 26794911
PLoS One. 2016 Dec 15;11(12):e0168610
pubmed: 27977792
Immunology. 2007 Apr;120(4):435-46
pubmed: 17313487
Eur J Immunol. 2009 Jul;39(7):1893-901
pubmed: 19585513
BMC Immunol. 2010 Jun 21;11:30
pubmed: 20565954
Antioxidants (Basel). 2020 Nov 04;9(11):
pubmed: 33158288
Front Immunol. 2018 Feb 09;9:169
pubmed: 29479350
Mech Ageing Dev. 2009 Oct;130(10):681-90
pubmed: 19698733
Clin Exp Immunol. 2010 Nov;162(2):271-9
pubmed: 20854328
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Int J Obes (Lond). 2019 Nov;43(11):2189-2199
pubmed: 30979972
Vaccine. 2015 Aug 26;33(36):4422-9
pubmed: 26163925
Biogerontology. 2008 Oct;9(5):299-308
pubmed: 18369735
Front Immunol. 2018 Dec 12;9:2945
pubmed: 30619305
Obesity (Silver Spring). 2016 Mar;24(3):615-25
pubmed: 26857091
Trends Cardiovasc Med. 2016 May;26(4):364-73
pubmed: 26654259
Immun Ageing. 2011 Jan 08;8(1):2
pubmed: 21214947
Blood. 2000 May 1;95(9):2860-8
pubmed: 10779432
Front Biosci. 2002 May 01;7:d1056-183
pubmed: 11991846
Immunol Res. 2018 Apr;66(2):234-244
pubmed: 29560551
Oxid Med Cell Longev. 2020 Sep 9;2020:1057570
pubmed: 32963689
Diabetes. 2012 Feb;61(2):401-8
pubmed: 22228716
Eur Heart J. 2010 Feb;31(3):369-76
pubmed: 19687164
Vaccine. 2000 Feb 25;18(16):1613-20
pubmed: 10689137
J Endocrinol. 2014 Jan 08;220(2):T47-59
pubmed: 24403378
Obes Surg. 2005 Nov-Dec;15(10):1463-8
pubmed: 16354528
Mol Nutr Food Res. 2016 Jan;60(1):43-57
pubmed: 26331761
Ann N Y Acad Sci. 2000 Jun;908:244-54
pubmed: 10911963
Exp Gerontol. 1999 Apr;34(2):253-65
pubmed: 10363791
FEBS Lett. 2005 Apr 11;579(10):2035-9
pubmed: 15811314
Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2322-30
pubmed: 21799175
Mediators Inflamm. 2010;2010:
pubmed: 20706689
J Immunol Res. 2016;2016:8426874
pubmed: 27493973
Exp Gerontol. 2018 Jul 1;107:55-58
pubmed: 28687479
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263296